MMedication Read More Follow safeguards to ensure your medications are safe and effectiveJuly 3, 2026 Many people live longer and with better quality today because of the medications they take. But medications can…
MMedication Read More Everything you need to know about GLP-1s for weight lossJuly 3, 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as “breakthrough” drugs in 2023 — and their popularity has soared since. …
MMedication Read More Judge suspends Colorado’s price cap on prescription drug EmbrelJuly 3, 2026 DENVER — Colorado’s first attempt to cap the price of an unaffordable prescription drug has been blocked by…
MMedication Read More Judge blocks Colorado price cap on the prescription drug EnbrelJuly 3, 2026 A federal judge has temporarily blocked Colorado’s first-in-the-nation price cap on a specific prescription drug, saying that it…
MMedication Read More Illegal weight loss drug floods SAJuly 3, 2026 The man at the Johannesburg gym had an answer for every question. The injectable he was selling was…
MMedication Read More What are statins? The uses and side effects of cholesterol medicationJuly 3, 2026 Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
MMedication Read More Pharmacist warns of heat risks for people on common medicationsJuly 3, 2026 As hot temperatures pummel central Iowa, you may be more likely to experience heat-related side effects on certain…
MMedication Read More Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’July 3, 2026 Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
MMedication Read More Canada approves generic version of Wegovy for weight lossJuly 3, 2026 FILE – A dosage of Wegovy, March 1, 2024 in Front Royal, Va. (AP Photo/Amanda Andrade-Rhoades, File) –…
MMedication Read More GLP-1s for Addiction: Are We There Yet?July 3, 2026 Substance use disorders (SUDs) may become the next therapeutic target for GLP-1 receptor agonists (GLP-1s). Although the evidence…
MMedication Read More Most ‘GLP-1 Nonresponders’ Never Get a Fair ShotJuly 3, 2026 I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
MMedication Read More China bans pet anaesthetic tiletamine after waves of young people vape drugJuly 3, 2026 China has banned tiletamine, a common veterinary anaesthetic, after its recreational inhalation among young people escalated sharply. Since…